世界の硫酸モルヒネ市場インサイト及び予測(錠剤、注射液、内服液)

◆英語タイトル:Global Morphine Sulphate Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22DE19247)◆商品コード:QY22DE19247
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年12月
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19パンデミックとロシア・ウクライナ戦争の影響により、硫酸モルヒネの世界市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
硫酸モルヒネのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
硫酸モルヒネの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
硫酸モルヒネのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面に関しては、当レポートは2017年から2022年までの硫酸モルヒネの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面に関しては、当レポートは2017年から2022年までの地域別、企業別、種類別、用途別の硫酸モルヒネの売上および2028年までの予測に焦点を当てています。

硫酸モルヒネのグローバル主要企業には、Mundi Pharma、Bard Pharma、Qinhai Zhiyao、Nepharm、Mayinglong、Padagis、Piramal Enterprises、Actavis、Akacia Healthcare、AbbVie、Allied Drug、Angelini Pharma、ANI Pharma、Apotex、Arrow Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

硫酸モルヒネ市場は、種類と用途によって区分されます。世界の硫酸モルヒネ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
錠剤、注射液、内服液

【用途別セグメント】
病院、クリニック、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 硫酸モルヒネ製品概要
- 種類別市場(錠剤、注射液、内服液)
- 用途別市場(病院、クリニック、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の硫酸モルヒネ販売量予測2017-2028
- 世界の硫酸モルヒネ売上予測2017-2028
- 硫酸モルヒネの地域別販売量
- 硫酸モルヒネの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別硫酸モルヒネ販売量
- 主要メーカー別硫酸モルヒネ売上
- 主要メーカー別硫酸モルヒネ価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(錠剤、注射液、内服液)
- 硫酸モルヒネの種類別販売量
- 硫酸モルヒネの種類別売上
- 硫酸モルヒネの種類別価格
・用途別市場規模(病院、クリニック、その他)
- 硫酸モルヒネの用途別販売量
- 硫酸モルヒネの用途別売上
- 硫酸モルヒネの用途別価格
・北米市場
- 北米の硫酸モルヒネ市場規模(種類別、用途別)
- 主要国別の硫酸モルヒネ市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの硫酸モルヒネ市場規模(種類別、用途別)
- 主要国別の硫酸モルヒネ市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の硫酸モルヒネ市場規模(種類別、用途別)
- 主要国別の硫酸モルヒネ市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の硫酸モルヒネ市場規模(種類別、用途別)
- 主要国別の硫酸モルヒネ市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの硫酸モルヒネ市場規模(種類別、用途別)
- 主要国別の硫酸モルヒネ市場規模(トルコ、サウジアラビア)
・企業情報
Mundi Pharma、Bard Pharma、Qinhai Zhiyao、Nepharm、Mayinglong、Padagis、Piramal Enterprises、Actavis、Akacia Healthcare、AbbVie、Allied Drug、Angelini Pharma、ANI Pharma、Apotex、Arrow Pharma
・産業チェーン及び販売チャネル分析
- 硫酸モルヒネの産業チェーン分析
- 硫酸モルヒネの原材料
- 硫酸モルヒネの生産プロセス
- 硫酸モルヒネの販売及びマーケティング
- 硫酸モルヒネの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 硫酸モルヒネの産業動向
- 硫酸モルヒネのマーケットドライバー
- 硫酸モルヒネの課題
- 硫酸モルヒネの阻害要因
・主な調査結果

Morphine sulfate extended-release tablets are powerful analgesics, mainly suitable for analgesia in patients with severe cancer pain
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Morphine Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Morphine Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Morphine Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Morphine Sulphate include Mundi Pharma, Bard Pharma, Qinhai Zhiyao, Nepharm, Mayinglong, Padagis, Piramal Enterprises, Actavis and Akacia Healthcare, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Morphine Sulphate manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Morphine Sulphate market. Further, it explains the major drivers and regional dynamics of the global Morphine Sulphate market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Mundi Pharma
Bard Pharma
Qinhai Zhiyao
Nepharm
Mayinglong
Padagis
Piramal Enterprises
Actavis
Akacia Healthcare
AbbVie
Allied Drug
Angelini Pharma
ANI Pharma
Apotex
Arrow Pharma
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by age form and by application segments based on sales, price, and value for the period 2017-2028.
Morphine Sulphate Segment Dosage Form
Tablets
Solution for Injection
Oral Liquid
Morphine Sulphate Segment by Application
Hospital
Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Morphine Sulphate market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Morphine Sulphate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Morphine Sulphate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Morphine Sulphate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Morphine Sulphate sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Morphine Sulphate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Morphine Sulphate sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Mundi Pharma, Bard Pharma, Qinhai Zhiyao, Nepharm, Mayinglong, Padagis, Piramal Enterprises, Actavis and Akacia Healthcare, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Morphine Sulphate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Morphine Sulphate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by age form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by age form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by age form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by age form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by age form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morphine Sulphate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Study Coverage
1.1 Morphine Sulphate Product Introduction
1.2 Market Dosage Form
1.2.1 Global Morphine Sulphate Market Size Growth Rate Dosage Form, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Solution for Injection
1.2.4 Oral Liquid
1.3 Market by Application
1.3.1 Global Morphine Sulphate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Morphine Sulphate Sales Estimates and Forecasts 2017-2028
2.2 Global Morphine Sulphate Revenue Estimates and Forecasts 2017-2028
2.3 Global Morphine Sulphate Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Morphine Sulphate Sales by Region
2.4.1 Global Morphine Sulphate Sales by Region (2017-2022)
2.4.2 Global Sales Morphine Sulphate by Region (2023-2028)
2.5 Global Morphine Sulphate Revenue by Region
2.5.1 Global Morphine Sulphate Revenue by Region (2017-2022)
2.5.2 Global Morphine Sulphate Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Morphine Sulphate Sales by Manufacturers
3.1.1 Global Top Morphine Sulphate Manufacturers by Sales (2017-2022)
3.1.2 Global Morphine Sulphate Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Morphine Sulphate in 2021
3.2 Global Morphine Sulphate Revenue by Manufacturers
3.2.1 Global Morphine Sulphate Revenue by Manufacturers (2017-2022)
3.2.2 Global Morphine Sulphate Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Morphine Sulphate Revenue in 2021
3.3 Global Morphine Sulphate Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Morphine Sulphate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Morphine Sulphate Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size Dosage Form
4.1 Global Morphine Sulphate Sales Dosage Form
4.1.1 Global Morphine Sulphate Historical Sales Dosage Form (2017-2022)
4.1.2 Global Morphine Sulphate Forecasted Sales Dosage Form (2023-2028)
4.1.3 Global Morphine Sulphate Sales Market Share Dosage Form (2017-2028)
4.2 Global Morphine Sulphate Revenue Dosage Form
4.2.1 Global Morphine Sulphate Historical Revenue Dosage Form (2017-2022)
4.2.2 Global Morphine Sulphate Forecasted Revenue Dosage Form (2023-2028)
4.2.3 Global Morphine Sulphate Revenue Market Share Dosage Form (2017-2028)
4.3 Global Morphine Sulphate Price Dosage Form
4.3.1 Global Morphine Sulphate Price Dosage Form (2017-2022)
4.3.2 Global Morphine Sulphate Price Forecast Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Morphine Sulphate Sales by Application
5.1.1 Global Morphine Sulphate Historical Sales by Application (2017-2022)
5.1.2 Global Morphine Sulphate Forecasted Sales by Application (2023-2028)
5.1.3 Global Morphine Sulphate Sales Market Share by Application (2017-2028)
5.2 Global Morphine Sulphate Revenue by Application
5.2.1 Global Morphine Sulphate Historical Revenue by Application (2017-2022)
5.2.2 Global Morphine Sulphate Forecasted Revenue by Application (2023-2028)
5.2.3 Global Morphine Sulphate Revenue Market Share by Application (2017-2028)
5.3 Global Morphine Sulphate Price by Application
5.3.1 Global Morphine Sulphate Price by Application (2017-2022)
5.3.2 Global Morphine Sulphate Price Forecast by Application (2023-2028)
6 North America
6.1 North America Morphine Sulphate Market Size Dosage Form
6.1.1 North America Morphine Sulphate Sales Dosage Form (2017-2028)
6.1.2 North America Morphine Sulphate Revenue Dosage Form (2017-2028)
6.2 North America Morphine Sulphate Market Size by Application
6.2.1 North America Morphine Sulphate Sales by Application (2017-2028)
6.2.2 North America Morphine Sulphate Revenue by Application (2017-2028)
6.3 North America Morphine Sulphate Market Size by Country
6.3.1 North America Morphine Sulphate Sales by Country (2017-2028)
6.3.2 North America Morphine Sulphate Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Morphine Sulphate Market Size Dosage Form
7.1.1 Europe Morphine Sulphate Sales Dosage Form (2017-2028)
7.1.2 Europe Morphine Sulphate Revenue Dosage Form (2017-2028)
7.2 Europe Morphine Sulphate Market Size by Application
7.2.1 Europe Morphine Sulphate Sales by Application (2017-2028)
7.2.2 Europe Morphine Sulphate Revenue by Application (2017-2028)
7.3 Europe Morphine Sulphate Market Size by Country
7.3.1 Europe Morphine Sulphate Sales by Country (2017-2028)
7.3.2 Europe Morphine Sulphate Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Morphine Sulphate Market Size Dosage Form
8.1.1 Asia Pacific Morphine Sulphate Sales Dosage Form (2017-2028)
8.1.2 Asia Pacific Morphine Sulphate Revenue Dosage Form (2017-2028)
8.2 Asia Pacific Morphine Sulphate Market Size by Application
8.2.1 Asia Pacific Morphine Sulphate Sales by Application (2017-2028)
8.2.2 Asia Pacific Morphine Sulphate Revenue by Application (2017-2028)
8.3 Asia Pacific Morphine Sulphate Market Size by Region
8.3.1 Asia Pacific Morphine Sulphate Sales by Region (2017-2028)
8.3.2 Asia Pacific Morphine Sulphate Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Morphine Sulphate Market Size Dosage Form
9.1.1 Latin America Morphine Sulphate Sales Dosage Form (2017-2028)
9.1.2 Latin America Morphine Sulphate Revenue Dosage Form (2017-2028)
9.2 Latin America Morphine Sulphate Market Size by Application
9.2.1 Latin America Morphine Sulphate Sales by Application (2017-2028)
9.2.2 Latin America Morphine Sulphate Revenue by Application (2017-2028)
9.3 Latin America Morphine Sulphate Market Size by Country
9.3.1 Latin America Morphine Sulphate Sales by Country (2017-2028)
9.3.2 Latin America Morphine Sulphate Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Morphine Sulphate Market Size Dosage Form
10.1.1 Middle East and Africa Morphine Sulphate Sales Dosage Form (2017-2028)
10.1.2 Middle East and Africa Morphine Sulphate Revenue Dosage Form (2017-2028)
10.2 Middle East and Africa Morphine Sulphate Market Size by Application
10.2.1 Middle East and Africa Morphine Sulphate Sales by Application (2017-2028)
10.2.2 Middle East and Africa Morphine Sulphate Revenue by Application (2017-2028)
10.3 Middle East and Africa Morphine Sulphate Market Size by Country
10.3.1 Middle East and Africa Morphine Sulphate Sales by Country (2017-2028)
10.3.2 Middle East and Africa Morphine Sulphate Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Mundi Pharma
11.1.1 Mundi Pharma Corporation Information
11.1.2 Mundi Pharma Overview
11.1.3 Mundi Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Mundi Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mundi Pharma Recent Developments
11.2 Bard Pharma
11.2.1 Bard Pharma Corporation Information
11.2.2 Bard Pharma Overview
11.2.3 Bard Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bard Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bard Pharma Recent Developments
11.3 Qinhai Zhiyao
11.3.1 Qinhai Zhiyao Corporation Information
11.3.2 Qinhai Zhiyao Overview
11.3.3 Qinhai Zhiyao Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Qinhai Zhiyao Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Qinhai Zhiyao Recent Developments
11.4 Nepharm
11.4.1 Nepharm Corporation Information
11.4.2 Nepharm Overview
11.4.3 Nepharm Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nepharm Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nepharm Recent Developments
11.5 Mayinglong
11.5.1 Mayinglong Corporation Information
11.5.2 Mayinglong Overview
11.5.3 Mayinglong Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mayinglong Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mayinglong Recent Developments
11.6 Padagis
11.6.1 Padagis Corporation Information
11.6.2 Padagis Overview
11.6.3 Padagis Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Padagis Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Padagis Recent Developments
11.7 Piramal Enterprises
11.7.1 Piramal Enterprises Corporation Information
11.7.2 Piramal Enterprises Overview
11.7.3 Piramal Enterprises Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Piramal Enterprises Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Piramal Enterprises Recent Developments
11.8 Actavis
11.8.1 Actavis Corporation Information
11.8.2 Actavis Overview
11.8.3 Actavis Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Actavis Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Actavis Recent Developments
11.9 Akacia Healthcare
11.9.1 Akacia Healthcare Corporation Information
11.9.2 Akacia Healthcare Overview
11.9.3 Akacia Healthcare Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Akacia Healthcare Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Akacia Healthcare Recent Developments
11.10 AbbVie
11.10.1 AbbVie Corporation Information
11.10.2 AbbVie Overview
11.10.3 AbbVie Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AbbVie Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AbbVie Recent Developments
11.11 Allied Drug
11.11.1 Allied Drug Corporation Information
11.11.2 Allied Drug Overview
11.11.3 Allied Drug Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Allied Drug Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Allied Drug Recent Developments
11.12 Angelini Pharma
11.12.1 Angelini Pharma Corporation Information
11.12.2 Angelini Pharma Overview
11.12.3 Angelini Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Angelini Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Angelini Pharma Recent Developments
11.13 ANI Pharma
11.13.1 ANI Pharma Corporation Information
11.13.2 ANI Pharma Overview
11.13.3 ANI Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 ANI Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 ANI Pharma Recent Developments
11.14 Apotex
11.14.1 Apotex Corporation Information
11.14.2 Apotex Overview
11.14.3 Apotex Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Apotex Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Apotex Recent Developments
11.15 Arrow Pharma
11.15.1 Arrow Pharma Corporation Information
11.15.2 Arrow Pharma Overview
11.15.3 Arrow Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Arrow Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Arrow Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Morphine Sulphate Industry Chain Analysis
12.2 Morphine Sulphate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Morphine Sulphate Production Mode & Process
12.4 Morphine Sulphate Sales and Marketing
12.4.1 Morphine Sulphate Sales Channels
12.4.2 Morphine Sulphate Distributors
12.5 Morphine Sulphate Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Morphine Sulphate Industry Trends
13.2 Morphine Sulphate Market Drivers
13.3 Morphine Sulphate Market Challenges
13.4 Morphine Sulphate Market Restraints
14 Key Findings in The Global Morphine Sulphate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Morphine Sulphate Market Size Growth Rate Dosage Form, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Solution for Injection
Table 4. Major Manufacturers of Oral Liquid
Table 5. Global Morphine Sulphate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Morphine Sulphate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Morphine Sulphate Sales by Region (2017-2022) & (Box)
Table 8. Global Morphine Sulphate Sales Market Share by Region (2017-2022)
Table 9. Global Morphine Sulphate Sales by Region (2023-2028) & (Box)
Table 10. Global Morphine Sulphate Sales Market Share by Region (2023-2028)
Table 11. Global Morphine Sulphate Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Morphine Sulphate Revenue Market Share by Region (2017-2022)
Table 13. Global Morphine Sulphate Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Morphine Sulphate Revenue Market Share by Region (2023-2028)
Table 15. Global Morphine Sulphate Sales by Manufacturers (2017-2022) & (Box)
Table 16. Global Morphine Sulphate Sales Share by Manufacturers (2017-2022)
Table 17. Global Morphine Sulphate Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Morphine Sulphate Revenue Share by Manufacturers (2017-2022)
Table 19. Morphine Sulphate Price by Manufacturers (2017-2022) &(US$/Box)
Table 20. Global Morphine Sulphate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Morphine Sulphate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Morphine Sulphate as of 2021)
Table 22. Morphine Sulphate Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Morphine Sulphate Product Offered
Table 24. Date of Manufacturers Enter into Morphine Sulphate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Morphine Sulphate Sales Dosage Form (2017-2022) & (Box)
Table 27. Global Morphine Sulphate Sales Dosage Form (2023-2028) & (Box)
Table 28. Global Morphine Sulphate Sales Share Dosage Form (2017-2022)
Table 29. Global Morphine Sulphate Sales Share Dosage Form (2023-2028)
Table 30. Global Morphine Sulphate Revenue Dosage Form (2017-2022) & (US$ Million)
Table 31. Global Morphine Sulphate Revenue Dosage Form (2023-2028) & (US$ Million)
Table 32. Global Morphine Sulphate Revenue Share Dosage Form (2017-2022)
Table 33. Global Morphine Sulphate Revenue Share Dosage Form (2023-2028)
Table 34. Morphine Sulphate Price Dosage Form (2017-2022) & (US$/Box)
Table 35. Global Morphine Sulphate Price Forecast Dosage Form (2023-2028) & (US$/Box)
Table 36. Global Morphine Sulphate Sales by Application (2017-2022) & (Box)
Table 37. Global Morphine Sulphate Sales by Application (2023-2028) & (Box)
Table 38. Global Morphine Sulphate Sales Share by Application (2017-2022)
Table 39. Global Morphine Sulphate Sales Share by Application (2023-2028)
Table 40. Global Morphine Sulphate Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Morphine Sulphate Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Morphine Sulphate Revenue Share by Application (2017-2022)
Table 43. Global Morphine Sulphate Revenue Share by Application (2023-2028)
Table 44. Morphine Sulphate Price by Application (2017-2022) & (US$/Box)
Table 45. Global Morphine Sulphate Price Forecast by Application (2023-2028) & (US$/Box)
Table 46. North America Morphine Sulphate Sales Dosage Form (2017-2022) & (Box)
Table 47. North America Morphine Sulphate Sales Dosage Form (2023-2028) & (Box)
Table 48. North America Morphine Sulphate Revenue Dosage Form (2017-2022) & (US$ Million)
Table 49. North America Morphine Sulphate Revenue Dosage Form (2023-2028) & (US$ Million)
Table 50. North America Morphine Sulphate Sales by Application (2017-2022) & (Box)
Table 51. North America Morphine Sulphate Sales by Application (2023-2028) & (Box)
Table 52. North America Morphine Sulphate Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Morphine Sulphate Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Morphine Sulphate Sales by Country (2017-2022) & (Box)
Table 55. North America Morphine Sulphate Sales by Country (2023-2028) & (Box)
Table 56. North America Morphine Sulphate Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Morphine Sulphate Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Morphine Sulphate Sales Dosage Form (2017-2022) & (Box)
Table 59. Europe Morphine Sulphate Sales Dosage Form (2023-2028) & (Box)
Table 60. Europe Morphine Sulphate Revenue Dosage Form (2017-2022) & (US$ Million)
Table 61. Europe Morphine Sulphate Revenue Dosage Form (2023-2028) & (US$ Million)
Table 62. Europe Morphine Sulphate Sales by Application (2017-2022) & (Box)
Table 63. Europe Morphine Sulphate Sales by Application (2023-2028) & (Box)
Table 64. Europe Morphine Sulphate Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Morphine Sulphate Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Morphine Sulphate Sales by Country (2017-2022) & (Box)
Table 67. Europe Morphine Sulphate Sales by Country (2023-2028) & (Box)
Table 68. Europe Morphine Sulphate Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Morphine Sulphate Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Morphine Sulphate Sales Dosage Form (2017-2022) & (Box)
Table 71. Asia Pacific Morphine Sulphate Sales Dosage Form (2023-2028) & (Box)
Table 72. Asia Pacific Morphine Sulphate Revenue Dosage Form (2017-2022) & (US$ Million)
Table 73. Asia Pacific Morphine Sulphate Revenue Dosage Form (2023-2028) & (US$ Million)
Table 74. Asia Pacific Morphine Sulphate Sales by Application (2017-2022) & (Box)
Table 75. Asia Pacific Morphine Sulphate Sales by Application (2023-2028) & (Box)
Table 76. Asia Pacific Morphine Sulphate Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Morphine Sulphate Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Morphine Sulphate Sales by Region (2017-2022) & (Box)
Table 79. Asia Pacific Morphine Sulphate Sales by Region (2023-2028) & (Box)
Table 80. Asia Pacific Morphine Sulphate Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Morphine Sulphate Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Morphine Sulphate Sales Dosage Form (2017-2022) & (Box)
Table 83. Latin America Morphine Sulphate Sales Dosage Form (2023-2028) & (Box)
Table 84. Latin America Morphine Sulphate Revenue Dosage Form (2017-2022) & (US$ Million)
Table 85. Latin America Morphine Sulphate Revenue Dosage Form (2023-2028) & (US$ Million)
Table 86. Latin America Morphine Sulphate Sales by Application (2017-2022) & (Box)
Table 87. Latin America Morphine Sulphate Sales by Application (2023-2028) & (Box)
Table 88. Latin America Morphine Sulphate Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Morphine Sulphate Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Morphine Sulphate Sales by Country (2017-2022) & (Box)
Table 91. Latin America Morphine Sulphate Sales by Country (2023-2028) & (Box)
Table 92. Latin America Morphine Sulphate Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Morphine Sulphate Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Morphine Sulphate Sales Dosage Form (2017-2022) & (Box)
Table 95. Middle East and Africa Morphine Sulphate Sales Dosage Form (2023-2028) & (Box)
Table 96. Middle East and Africa Morphine Sulphate Revenue Dosage Form (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Morphine Sulphate Revenue Dosage Form (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Morphine Sulphate Sales by Application (2017-2022) & (Box)
Table 99. Middle East and Africa Morphine Sulphate Sales by Application (2023-2028) & (Box)
Table 100. Middle East and Africa Morphine Sulphate Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Morphine Sulphate Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Morphine Sulphate Sales by Country (2017-2022) & (Box)
Table 103. Middle East and Africa Morphine Sulphate Sales by Country (2023-2028) & (Box)
Table 104. Middle East and Africa Morphine Sulphate Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Morphine Sulphate Revenue by Country (2023-2028) & (US$ Million)
Table 106. Mundi Pharma Corporation Information
Table 107. Mundi Pharma Description and Major Businesses
Table 108. Mundi Pharma Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 109. Mundi Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Mundi Pharma Recent Developments
Table 111. Bard Pharma Corporation Information
Table 112. Bard Pharma Description and Major Businesses
Table 113. Bard Pharma Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 114. Bard Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Bard Pharma Recent Developments
Table 116. Qinhai Zhiyao Corporation Information
Table 117. Qinhai Zhiyao Description and Major Businesses
Table 118. Qinhai Zhiyao Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 119. Qinhai Zhiyao Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Qinhai Zhiyao Recent Developments
Table 121. Nepharm Corporation Information
Table 122. Nepharm Description and Major Businesses
Table 123. Nepharm Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 124. Nepharm Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Nepharm Recent Developments
Table 126. Mayinglong Corporation Information
Table 127. Mayinglong Description and Major Businesses
Table 128. Mayinglong Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 129. Mayinglong Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Mayinglong Recent Developments
Table 131. Padagis Corporation Information
Table 132. Padagis Description and Major Businesses
Table 133. Padagis Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 134. Padagis Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Padagis Recent Developments
Table 136. Piramal Enterprises Corporation Information
Table 137. Piramal Enterprises Description and Major Businesses
Table 138. Piramal Enterprises Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 139. Piramal Enterprises Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Piramal Enterprises Recent Developments
Table 141. Actavis Corporation Information
Table 142. Actavis Description and Major Businesses
Table 143. Actavis Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 144. Actavis Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Actavis Recent Developments
Table 146. Akacia Healthcare Corporation Information
Table 147. Akacia Healthcare Description and Major Businesses
Table 148. Akacia Healthcare Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 149. Akacia Healthcare Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Akacia Healthcare Recent Developments
Table 151. AbbVie Corporation Information
Table 152. AbbVie Description and Major Businesses
Table 153. AbbVie Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 154. AbbVie Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. AbbVie Recent Developments
Table 156. Allied Drug Corporation Information
Table 157. Allied Drug Description and Major Businesses
Table 158. Allied Drug Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 159. Allied Drug Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Allied Drug Recent Developments
Table 161. Angelini Pharma Corporation Information
Table 162. Angelini Pharma Description and Major Businesses
Table 163. Angelini Pharma Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 164. Angelini Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Angelini Pharma Recent Developments
Table 166. ANI Pharma Corporation Information
Table 167. ANI Pharma Description and Major Businesses
Table 168. ANI Pharma Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 169. ANI Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. ANI Pharma Recent Developments
Table 171. Apotex Corporation Information
Table 172. Apotex Description and Major Businesses
Table 173. Apotex Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 174. Apotex Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Apotex Recent Developments
Table 176. Arrow Pharma Corporation Information
Table 177. Arrow Pharma Description and Major Businesses
Table 178. Arrow Pharma Morphine Sulphate Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 179. Arrow Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Arrow Pharma Recent Developments
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Morphine Sulphate Distributors List
Table 184. Morphine Sulphate Customers List
Table 185. Morphine Sulphate Market Trends
Table 186. Morphine Sulphate Market Drivers
Table 187. Morphine Sulphate Market Challenges
Table 188. Morphine Sulphate Market Restraints
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Morphine Sulphate Product Picture
Figure 2. Global Morphine Sulphate Market Share Dosage Form in 2021 & 2028
Figure 3. Tablets Product Picture
Figure 4. Solution for Injection Product Picture
Figure 5. Oral Liquid Product Picture
Figure 6. Global Morphine Sulphate Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Morphine Sulphate Report Years Considered
Figure 11. Global Morphine Sulphate Sales 2017-2028 (Box)
Figure 12. Global Morphine Sulphate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Morphine Sulphate Revenue 2017-2028 (US$ Million)
Figure 14. Global Morphine Sulphate Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Morphine Sulphate Sales Market Share by Region (2017-2022)
Figure 16. Global Morphine Sulphate Sales Market Share by Region (2023-2028)
Figure 17. North America Morphine Sulphate Sales YoY (2017-2028) & (Box)
Figure 18. North America Morphine Sulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Morphine Sulphate Sales YoY (2017-2028) & (Box)
Figure 20. Europe Morphine Sulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Morphine Sulphate Sales YoY (2017-2028) & (Box)
Figure 22. Asia-Pacific Morphine Sulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Morphine Sulphate Sales YoY (2017-2028) & (Box)
Figure 24. Latin America Morphine Sulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Morphine Sulphate Sales YoY (2017-2028) & (Box)
Figure 26. Middle East & Africa Morphine Sulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Morphine Sulphate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Morphine Sulphate in the World: Market Share by Morphine Sulphate Revenue in 2021
Figure 29. Global Morphine Sulphate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Morphine Sulphate Sales Market Share Dosage Form (2017-2028)
Figure 31. Global Morphine Sulphate Revenue Market Share Dosage Form (2017-2028)
Figure 32. Global Morphine Sulphate Sales Market Share by Application (2017-2028)
Figure 33. Global Morphine Sulphate Revenue Market Share by Application (2017-2028)
Figure 34. North America Morphine Sulphate Sales Market Share Dosage Form (2017-2028)
Figure 35. North America Morphine Sulphate Revenue Market Share Dosage Form (2017-2028)
Figure 36. North America Morphine Sulphate Sales Market Share by Application (2017-2028)
Figure 37. North America Morphine Sulphate Revenue Market Share by Application (2017-2028)
Figure 38. North America Morphine Sulphate Sales Share by Country (2017-2028)
Figure 39. North America Morphine Sulphate Revenue Share by Country (2017-2028)
Figure 40. United States Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Morphine Sulphate Sales Market Share Dosage Form (2017-2028)
Figure 43. Europe Morphine Sulphate Revenue Market Share Dosage Form (2017-2028)
Figure 44. Europe Morphine Sulphate Sales Market Share by Application (2017-2028)
Figure 45. Europe Morphine Sulphate Revenue Market Share by Application (2017-2028)
Figure 46. Europe Morphine Sulphate Sales Share by Country (2017-2028)
Figure 47. Europe Morphine Sulphate Revenue Share by Country (2017-2028)
Figure 48. Germany Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 49. France Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Morphine Sulphate Sales Market Share Dosage Form (2017-2028)
Figure 54. Asia Pacific Morphine Sulphate Revenue Market Share Dosage Form (2017-2028)
Figure 55. Asia Pacific Morphine Sulphate Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Morphine Sulphate Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Morphine Sulphate Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Morphine Sulphate Revenue Share by Region (2017-2028)
Figure 59. China Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 62. India Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Morphine Sulphate Sales Market Share Dosage Form (2017-2028)
Figure 69. Latin America Morphine Sulphate Revenue Market Share Dosage Form (2017-2028)
Figure 70. Latin America Morphine Sulphate Sales Market Share by Application (2017-2028)
Figure 71. Latin America Morphine Sulphate Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Morphine Sulphate Sales Share by Country (2017-2028)
Figure 73. Latin America Morphine Sulphate Revenue Share by Country (2017-2028)
Figure 74. Mexico Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Morphine Sulphate Sales Market Share Dosage Form (2017-2028)
Figure 79. Middle East and Africa Morphine Sulphate Revenue Market Share Dosage Form (2017-2028)
Figure 80. Middle East and Africa Morphine Sulphate Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Morphine Sulphate Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Morphine Sulphate Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Morphine Sulphate Revenue Share by Country (2017-2028)
Figure 84. Turkey Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Morphine Sulphate Revenue (2017-2028) & (US$ Million)
Figure 87. Morphine Sulphate Value Chain
Figure 88. Morphine Sulphate Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の硫酸モルヒネ市場インサイト及び予測(錠剤、注射液、内服液)(Global Morphine Sulphate Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆